PHARMACEUTICAL COMPOUNDS

The invention provides new pyrazine derivatives of formula (I), or a tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined herein. The invention also provides pharmaceutical compositions comprising said compounds and to the use of said compounds...

Full description

Saved in:
Bibliographic Details
Main Authors ST DENIS, Jeffrey David, LIEBESCHUETZ, John Walter, JOHNSON, Christopher Norbert, DAY, James Edward Harvey, FUJIWARA, Hideto, HISCOCK, Steven Douglas, HOLVEY, Rhian Sara, BUCK, Ildiko Maria, WOODHEAD, Andrew James, HAMLETT, Christopher Charles Frederick, HOWARD, Steven, TWIGG, David Geoffrey, CHESSARI, Gianni, PALMER, Nicholas John
Format Patent
LanguageEnglish
Published 28.02.2024
Online AccessGet full text

Cover

Abstract The invention provides new pyrazine derivatives of formula (I), or a tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined herein. The invention also provides pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
AbstractList The invention provides new pyrazine derivatives of formula (I), or a tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined herein. The invention also provides pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Author HOLVEY, Rhian Sara
FUJIWARA, Hideto
HAMLETT, Christopher Charles Frederick
BUCK, Ildiko Maria
CHESSARI, Gianni
DAY, James Edward Harvey
ST DENIS, Jeffrey David
WOODHEAD, Andrew James
PALMER, Nicholas John
TWIGG, David Geoffrey
HOWARD, Steven
HISCOCK, Steven Douglas
LIEBESCHUETZ, John Walter
JOHNSON, Christopher Norbert
Author_xml – fullname: ST DENIS, Jeffrey David
– fullname: LIEBESCHUETZ, John Walter
– fullname: JOHNSON, Christopher Norbert
– fullname: DAY, James Edward Harvey
– fullname: FUJIWARA, Hideto
– fullname: HISCOCK, Steven Douglas
– fullname: HOLVEY, Rhian Sara
– fullname: BUCK, Ildiko Maria
– fullname: WOODHEAD, Andrew James
– fullname: HAMLETT, Christopher Charles Frederick
– fullname: HOWARD, Steven
– fullname: TWIGG, David Geoffrey
– fullname: CHESSARI, Gianni
– fullname: PALMER, Nicholas John
BookMark eNrjYmDJy89L5WSQCPBwDPJ1dHYNDfF0dvRRcPb3DfAP9XMJ5mFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8VGORgZGBgYm5kaWTsbEqAEA0O0hog
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID ZA202004729B
GroupedDBID EVB
ID FETCH-epo_espacenet_ZA202004729B3
IEDL.DBID EVB
IngestDate Fri Aug 16 05:56:45 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_ZA202004729B3
Notes Application Number: ZA20200004729
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240228&DB=EPODOC&CC=ZA&NR=202004729B
ParticipantIDs epo_espacenet_ZA202004729B
PublicationCentury 2000
PublicationDate 20240228
PublicationDateYYYYMMDD 2024-02-28
PublicationDate_xml – month: 02
  year: 2024
  text: 20240228
  day: 28
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies Taiho Pharmaceutical Co., Ltd
Otsuka Pharmaceutical Co., Ltd
RelatedCompanies_xml – name: Otsuka Pharmaceutical Co., Ltd
– name: Taiho Pharmaceutical Co., Ltd
Score 3.5319018
Snippet The invention provides new pyrazine derivatives of formula (I), or a tautomer or a solvate or a pharmaceutically acceptable salt thereof, wherein the...
SourceID epo
SourceType Open Access Repository
Title PHARMACEUTICAL COMPOUNDS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240228&DB=EPODOC&locale=&CC=ZA&NR=202004729B
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMbA0T0lKNTLUNU4yMdE1SUxN1rUwTEvUTTExSbIwTDRNTQSP6fr6mXmEmnhFmEYwMWTB9sKAzwktBx-OCMxRycD8XgIurwsQg1gu4LWVxfpJmUChfHu3EFsXNWjvGDRVYGSh5uJk6xrg7-LvrObsbBvlqOYXBJIDH4xo6cTMwApqRoPO2XcNcwLtSilArlLcBBnYAoCm5ZUIMTCl5gkzcDrDbl4TZuDwhU54A5nQvFcswiAR4OEY5Ovo7BoaAjrDQMHZ3zfAP9TPJViUQdHNNcTZQxdoRTzcP_FRjgjXGIsxsAD7-akSDApAbmpikqVhsmWyhYlxsmliqoFxsoFFmqFFSppZqmmSJIMUbnOk8ElKM3CBwgayE1uGgaWkqDRVFliXliTJgQMBAB_gdWk
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT4MwFH-Z0zhvOjVzfs3EcCPCKBsciIECQR0fmWCWXQiFkszDXBzGf99SmfOit7YveW1f8vryvn4FuJX0cUHoUBYVgpCIMpqLmlxmYoEQ0eRMpRmP6frByEvQ40ydteB10wvDcUI_OTgi06ic6XvF3-vVNohl89rK9R1ZsKW3ezc2bKHxjutUwVATbMtwotAOsYCxMTeFYFrTODCibu3A7pi5hDXOvvNi1V0pq98mxT2EvYhxW1ZH0KLLLnTw5ue1Luz7TcKbDRvdWx9DL_LMqW9iJ4lrDIMBDv0oTAL7-QRuXCfGnsi2SH_uk87N7WmUU2gzP5_2YMCmNCO6nOu5hpRczaik5JJWylpRjqhKzqD_N5_-f8Rr6HixP0knD8HTORzUcvruyr6AdvX-QS-ZXa3IFRfIF8LbeFQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PHARMACEUTICAL+COMPOUNDS&rft.inventor=ST+DENIS%2C+Jeffrey+David&rft.inventor=LIEBESCHUETZ%2C+John+Walter&rft.inventor=JOHNSON%2C+Christopher+Norbert&rft.inventor=DAY%2C+James+Edward+Harvey&rft.inventor=FUJIWARA%2C+Hideto&rft.inventor=HISCOCK%2C+Steven+Douglas&rft.inventor=HOLVEY%2C+Rhian+Sara&rft.inventor=BUCK%2C+Ildiko+Maria&rft.inventor=WOODHEAD%2C+Andrew+James&rft.inventor=HAMLETT%2C+Christopher+Charles+Frederick&rft.inventor=HOWARD%2C+Steven&rft.inventor=TWIGG%2C+David+Geoffrey&rft.inventor=CHESSARI%2C+Gianni&rft.inventor=PALMER%2C+Nicholas+John&rft.date=2024-02-28&rft.externalDBID=B&rft.externalDocID=ZA202004729B